Eva Karamitopoulou

Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material

Eva Karamitopoulou, Elias Perentes, Ioannis Diamantis et al. · Acta Neuropathologica · 1994 · 203 citations

Medicine, Oncology, Pathology +15

Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance

Martin Wartenberg, Silvia Cibin, Inti Zlobec et al. · Clinical Cancer Research · 2018 · 197 citations · Full text

Medicine, Oncology, Pathology +17

A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma

Nikki K. Lytle, L. Paige Ferguson, Nirakar Rajbhandari et al. · Cell · 2019 · 170 citations · Full text

Medicine, Cell Biology, Oncology +12

Tumour budding is a strong and independent prognostic factor in pancreatic cancer

Eva Karamitopoulou, Inti Zlobec, D. Born et al. · European Journal of Cancer · 2012 · 157 citations

Medicine, Cancer Biology, Oncology +10

RETRACTED ARTICLE: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer

José A. Galván, Inti Zlobec, Martin Wartenberg et al. · British Journal of Cancer · 2015 · 150 citations · Full text

Medicine, Cancer Biology, Oncology +17